Cytochrome p450 and chemical toxicology.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Chemical Research in Toxicology

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1021/TX700079ZPMID 18052394
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS

  2010cited by this paper
• The sparteine/debrisoquine (CYP2D6) oxidation polymorphism and the risk of lung cancer: A meta- analysis

  2009cited by this paper
• Adaptations for the Oxidation of Polycyclic Aromatic Hydrocarbons Exhibited by the Structure of Human P450 1A2*♦

  2007cited by this paper
• Untargeted analysis of mass spectrometry data for elucidation of metabolites and function of enzymes.

  2007cited by this paper
• Multiple Sequential Steps Involved in the Binding of Inhibitors to Cytochrome P450 3A4*

  2007cited by this paper
• CYP1A Induction and Human Risk Assessment: An Evolving Tale of in Vitro and in Vivo Studies

  2007cited by this paper
• Complex reactions catalyzed by cytochrome P450 enzymes.

  2007cited by this paper
• Applying mechanisms of chemical toxicity to predict drug safety.

  2007cited by this paper
• Kinetics and Thermodynamics of Ligand Binding by Cytochrome P450 3A4*

  2006cited by this paper
• A malleable catalyst dominates the metabolism of drugs

  2006cited by this paper
• Future of toxicology--mechanisms of toxicity and drug safety: where do we go from here?

  2006cited by this paper
• Activation of aminophenylnorharman, aminomethylphenylnorharman and aminophenylharman to genotoxic metabolites by human N-acetyltransferases and cytochrome P450 enzymes expressed in Salmonella typhimurium umu tester strains.

  2006cited by this paper
• Thiazolidinedione bioactivation: a comparison of the bioactivation potentials of troglitazone, rosiglitazone, and pioglitazone using stable isotope-labeled analogues and liquid chromatography tandem mass spectrometry.

  2006cited by this paper
• Metabolic and non-metabolic factors determining troglitazone hepatotoxicity: a review.

  2006cited by this paper
• Tumor-specific expression of the novel cytochrome P450 enzyme, CYP2W1.

  2006cited by this paper
• Structural basis for ligand promiscuity in cytochrome P450 3A4

  2006cited by this paper
• Recombinant Enzymes Overexpressed in Bacteria Show Broad Catalytic Specificity of Human Cytochrome P450 2W1 and Limited Activity of Human Cytochrome P450 2S1

  2006cited by this paper
• Pharmacogenomics: from bedside to clinical practice.

  2006cited by this paper
• Heterologous expression, purification, and properties of human cytochrome P450 27C1.

  2006cited by this paper
• Current views on the fundamental mechanisms of cytochrome P450 allosterism

  2006cited by this paper
• Intracellular signaling mechanisms of acetaminophen-induced liver cell death.

  2006cited by this paper
• Predicting in vivo drug interactions from in vitro drug discovery data

  2005cited by this paper
• Non-Michaelis-Menten kinetics in cytochrome P450-catalyzed reactions.

  2005cited by this paper
• Theoretical perspective on the structure and mechanism of cytochrome P450 enzymes.

  2005cited by this paper
• Original Contribution Biomarkers of oxidative stress study III. Effects of the nonsteroidal anti-inflammatory agents indomethacin and meclofenamic acid on measurements of oxidative products of lipids in CCl 4 poisoning

  2005cited by this paper
• Minimising the potential for metabolic activation in drug discovery

  2005cited by this paper
• Role of Metabolism in Drug-Induced Idiosyncratic Hepatotoxicity

  2005cited by this paper
• Cytochrome P450 3A4-catalyzed Testosterone 6β-Hydroxylation Stereochemistry, Kinetic Deuterium Isotope Effects, and Rate-limiting Steps*

  2005cited by this paper
• Function of human cytochrome P450s: characterization of the orphans.

  2005cited by this paper
• Mechanism-Based Inactivation of CYP3A by HIV Protease Inhibitors

  2005cited by this paper
• Elucidating mechanisms of drug-induced toxicity

  2005cited by this paper
• Cytochrome P-450 1A1 gene polymorphisms and risk of breast cancer: a HuGE review.

  2005cited by this paper
• In vitro ADME phenotyping in drug discovery: current challenges and future solutions.

  2005cited by this paper
• The final catalytic step of cytochrome p450 aromatase: a density functional theory study.

  2005cited by this paper
• THE CYP2E1-HUMANIZED TRANSGENIC MOUSE: ROLE OF CYP2E1 IN ACETAMINOPHEN HEPATOTOXICITY

  2005cited by this paper
• Biomarkers of oxidative stress study III. Effects of the nonsteroidal anti-inflammatory agents indomethacin and meclofenamic acid on measurements of oxidative products of lipids in CCl4 poisoning.

  2005cited by this paper
• Crystal Structure of Human Cytochrome P450 2D6*

  2005cited by this paper
• A comprehensive listing of bioactivation pathways of organic functional groups.

  2005cited by this paper
• Structures of human microsomal cytochrome P450 2A6 complexed with coumarin and methoxsalen

  2005cited by this paper
• Kinetic Analysis of Oxidation of Coumarins by Human Cytochrome P450 2A6*

  2005cited by this paper
• The Structure of Human Cytochrome P450 2C9 Complexed with Flurbiprofen at 2.0-Å Resolution*

  2004cited by this paper
• Mechanisms that regulate production of reactive oxygen species by cytochrome P450.

  2004cited by this paper
• Applying new biotechnologies to the study of occupational cancer--a workshop summary.

  2004cited by this paper
• Oral exposure to benzo[a]pyrene in the mouse: detoxication by inducible cytochrome P450 is more important than metabolic activation.

  2004cited by this paper
• Metabolism of Thalidomide in Liver Microsomes of Mice, Rabbits, and Humans

  2004cited by this paper
• Oxidative stress, toxicology, and pharmacology of CYP2E1.

  2004cited by this paper
• Drug-protein adducts: an industry perspective on minimizing the potential for drug bioactivation in drug discovery and development.

  2004cited by this paper
• Role of Aryl Hydrocarbon Receptor-mediated Induction of the CYP1 Enzymes in Environmental Toxicity and Cancer*

  2004cited by this paper
• Identification of cytochrome P-450s involved in the formation of APNH from norharman with aniline.

  2004cited by this paper
• Hydroxylation by the hydroperoxy-iron species in cytochrome P450 enzymes.

  2004cited by this paper
• Animal models of idiosyncratic drug reactions.

  2004cited by this paper
• DRUG-DRUG INTERACTIONS FOR UDP-GLUCURONOSYLTRANSFERASE SUBSTRATES: A PHARMACOKINETIC EXPLANATION FOR TYPICALLY OBSERVED LOW EXPOSURE (AUCI/AUC) RATIOS

  2004cited by this paper
• The Structure of Human Microsomal Cytochrome P450 3A4 Determined by X-ray Crystallography to 2.05-Å Resolution*

  2004cited by this paper
• Structure of Human Microsomal Cytochrome P450 2C8

  2004cited by this paper
• Crystal Structures of Human Cytochrome P450 3A4 Bound to Metyrapone and Progesterone

  2004cited by this paper
• Can the pharmaceutical industry reduce attrition rates?

  2004cited by this paper
• Bergamottin, lime juice, and red wine as inhibitors of cytochrome P450 3A4 activity: Comparison with grapefruit juice

  2003cited by this paper
• Aryl Hydrocarbon Hydroxylase Represents CYP1B1, and not CYP1A1, in Human Freshly Isolated White Cells

  2003cited by this paper
• De-orphanization of Cytochrome P450 2R1

  2003cited by this paper
• Crystal structure of human cytochrome P450 2C9 with bound warfarin

  2003cited by this paper
• Hepatotoxicity of thiazolidinediones

  2003cited by this paper
• Determination of the rate of reduction of oxyferrous cytochrome P450 2B4 by 5-deazariboflavin adenine dinucleotide T491V cytochrome P450 reductase.

  2003cited by this paper
• Aryl hydrocarbon hydroxylase represents CYP1B1, and not CYP1A1, in human freshly isolated white cells: trimodal distribution of Japanese population according to induction of CYP1B1 mRNA by environmental dioxins.

  2003cited by this paper
• An integrated view of aromatase and its inhibition.

  2003cited by this paper
• Reaction of aflatoxin B(1) oxidation products with lysine.

  2002cited by this paper
• Association between CYP2C9 genetic variants and anticoagulation-related outcomes during warfarin therapy.

  2002cited by this paper
• Alcoholic steatosis and steatohepatitis.

  2002cited by this paper
• Revisiting the mechanism of P450 enzymes with the radical clocks norcarane and spiro[2,5]octane.

  2002cited by this paper
• Cytochrome P450 2B1 mediates oxidant injury in puromycin-induced nephrotic syndrome.

  2002cited by this paper
• The CYP17 MspA1 polymorphism and breast cancer risk: a meta-analysis.

  2002cited by this paper
• Oxidizing species in the mechanism of cytochrome P450.

  2002cited by this paper
• Pyrene.pyrene complexes at the active site of cytochrome P450 3A4: evidence for a multiple substrate binding site.

  2002cited by this paper
• Mechanism-based inactivation of CYP2D6 by 5-fluoro-2-[4-[(2-phenyl-1H-imidazol-5-yl)methyl]-1-piperazinyl]pyrimidine.

  2001cited by this paper
• Reduction of aflatoxin B1 dialdehyde by rat and human aldo-keto reductases.

  2001cited by this paper
• Common and uncommon cytochrome P450 reactions related to metabolism and chemical toxicity.

  2001cited by this paper
• Heterotropic cooperativity of cytochrome P450 3A4 and potential drug-drug interactions.

  2001cited by this paper
• Studies on the metabolism of troglitazone to reactive intermediates in vitro and in vivo. Evidence for novel biotransformation pathways involving quinone methide formation and thiazolidinedione ring scission.

  2001cited by this paper
• Nonalcoholic steatosis and steatohepatitis. II. Cytochrome P-450 enzymes and oxidative stress.

  2001cited by this paper
• Metabolism of chemical carcinogens.

  2000cited by this paper
• Cytochrome P450-Catalyzed Hydroxylation of Mechanistic Probes that Distinguish between Radicals and Cations. Evidence for Cationic but Not for Radical Intermediates

  2000cited by this paper
• Elucidation of distinct ligand binding sites for cytochrome P450 3A4.

  2000cited by this paper
• Oxidation of 1,2,4,5-Tetramethoxybenzene to a Cation Radical by Cytochrome P450

  2000cited by this paper
• Kinetics of hydrolysis and reaction of aflatoxin B1 exo-8,9-epoxide and relevance to toxicity and detoxication.

  1999cited by this paper
• Kinetics of Cytochrome P450 2E1-Catalyzed Oxidation of Ethanol to Acetic Acid via Acetaldehyde*

  1999cited by this paper
• Metabolism of benzo[a]pyrene to trans-7,8-dihydroxy-7, 8-dihydrobenzo[a]pyrene by recombinant human cytochrome P450 1B1 and purified liver epoxide hydrolase.

  1999cited by this paper
• Development of cancer chemopreventive agents: oltipraz as a paradigm.

  1999cited by this paper
• Oxidation of troglitazone to a quinone-type metabolite catalyzed by cytochrome P-450 2C8 and P-450 3A4 in human liver microsomes.

  1999cited by this paper
• Meta-analysis of studies of the CYP2D6 polymorphism in relation to lung cancer and Parkinson's disease.

  1998cited by this paper
• Two Cases of Severe Clinical and Histologic Hepatotoxicity Associated with Troglitazone

  1998cited by this paper
• Structural determination of a mutagenic aminophenylnorharman produced by the co-mutagen norharman with aniline.

  1998cited by this paper
• Formation and repair of DNA lesions in the p53 gene: Relation to cancer mutations?

  1998cited by this paper
• Analysis of human cytochrome P450 3A4 cooperativity: construction and characterization of a site-directed mutant that displays hyperbolic steroid hydroxylation kinetics.

  1998cited by this paper
• Protection against acetaminophen toxicity in CYP1A2 and CYP2E1 double-null mice.

  1998cited by this paper
• Reaction of aflatoxin B1 exo-8,9-epoxide with DNA: kinetic analysis of covalent binding and DNA-induced hydrolysis.

  1997cited by this paper
• Kinetics of ferric cytochrome P450 reduction by NADPH-cytochrome P450 reductase: rapid reduction in the absence of substrate and variations among cytochrome P450 systems.

  1997cited by this paper
• Reaction of aflatoxin B1 exo-8,9-epoxide with DNA: kinetic analysis of covalent binding and DNA-induced hydrolysis.

  1997cited by this paper
• Cooperativity in oxidations catalyzed by cytochrome P450 3A4.

  1997cited by this paper
• Conjugation of highly reactive aflatoxin B1 exo-8,9-epoxide catalyzed by rat and human glutathione transferases: estimation of kinetic parameters.

  1997cited by this paper
• Aflatoxin B1 8,9-epoxide hydrolysis in the presence of rat and human epoxide hydrolase.

  1997cited by this paper
• Grapefruit juice—terfenadine single‐dose interaction: Magnitude, mechanism, and relevance

  1997cited by this paper

• In silico profiling of commonly used insecticides, herbicides, and fungicides in Asia: a comparative chemical and toxicological study

  2026cites this paper
• Analgesic effects of bulleyaconitine A: new advances in research from ion channel targets to clinical translation

  2026cites this paper
• In Silico Study of Luteolin and Eriodictyol as Xanthine Oxidase Inhibitors: An Integrated Approach Using Virtual Screening, DFT, Molecular Docking, MD Simulations, and ADMET Analysis

  2026cites this paper
• In Vitro Evaluation and Network Pharmacology Analysis of the Antimicrobial Activity of Pistacia lentiscus

  2026cites this paper
• Interaction-Aware Adaptive Network for Drug-Drug Interaction Prediction

  2026cites this paper
• Pharmacists in Interprofessional Critical Care

  2026cites this paper
• High-Throughput Testing for Unknown Mutagens and Cytotoxica via Duplex Planar Ames-Cytotoxicity Bioassay Including Metabolic S9 Activation.

  2026cites this paper
• Toxicoepigenomics: Epigenetic disruption by environmental exposures and implications for biomarker development.

  2026cites this paper
• Potential of ethyl acetate and acetone extracts from Montrichardia linifera leaves: Chemical characterization, in vitro study, molecular docking ad ADME-TOX.

  2026cites this paper
• Identification of plant-derived secondary metabolites as potential CDK2 inhibitors against colorectal cancer: Molecular docking, dynamics simulations and DFT study

  2026cites this paper
• Molecular docking, dynamics, and DFT-based discovery of novel CTX-M β-lactamase inhibitors in Klebsiella pneumoniae

  2026cites this paper
• A Sustainable Strategy for Gastrointestinal Nematode Control in Sheep

  2026cites this paper
• Ferroptosis as a Novel Therapeutic Strategy to Overcome Multidrug Resistance in Colorectal Cancer.

  2026cites this paper
• Weathering-modulated gut-liver toxicity of tire wear particles in zebrafish: Source-specific effects and multi-omics insights

  2026cites this paper
• The impact of polystyrene nanoplastics on the chicken gut and liver: Based on transcriptomics and microbiomics.

  2026cites this paper
• Using an integrative multi-omics and in vitro approach to investigate the role of tris(2-butoxyethyl) phosphate in promoting hepatic steatosis

  2026cites this paper
• ATTNSOM: Learning Cross-Isoform Attention for Cytochrome P450 Site-of-Metabolism

  2026cites this paper
• Assessment of the anticancer and antimetastatic effects of monocarbonyl analogs of curcumin, C66 and B2BrBC, in breast cancer cells

  2026cites this paper
• In Silico Study of Bioactive Compounds from Red Fruit (Pandanus conoideus Lamk.) as Inhibitors of Human Alcohol Dehydrogenase

  2025cites this paper
• Prediction and Assessment of Anticancer, Antiproliferative, Pharmacokinetic Properties, and Human Serum Albumin Binding Propensity of a New Bioactive Marine Cyclic Dipeptide from Exiguobacterium profundum

  2025cites this paper
• Classification of Mitochondrial Protonophoric Uncouplers and their Modifications in Biological Environment

  2025cites this paper
• On the Question of the Regio-, Stereoselectivity and the Molecular Mechanism of the (3+2) Cycloaddition Reaction Between (Z)-C-Phenyl-N-alkyl(phenyl)nitrones and (E)-3-(Methylsulfonyl)-propenoic Acid Derivatives

  2025cites this paper
• Identification of Potential Anti-Tubercular Inhibitors through Virtual Screening, DFT, and Molecular Dynamics Simulation Studies

  2025cites this paper
• In vitro activity of two cycloartane-type triterpenoid saponins from Astragalus glycyphyllos on liver microsomes, hepatocytes, and isoforms of cytochrome P450

  2025influential citation
• The Potential Therapeutic Effects of MEAI in the Treatment of Alcohol Use Disorder

  2025cites this paper
• Experimental Evaluation of Avocado Honey's Wound Healing Properties: Physicochemical, Antibacterial, Anti-inflammatory, and Proliferative Effects Combined with In Silico Toxicity and Molecular Docking Analysis.

  2025cites this paper
• Mitigating oxidative stress toxicities of environmental pollutants by antioxidant nanoformulations

  2025cites this paper
• Characterization of small molecule drug clearance mechanisms using in vitro and in vivo approaches in drug discovery and development

  2025cites this paper
• Genetic Diversity of Cytochrome P450 2C9 (CYP2C9) in HIV/AIDS Positive Patients Regarding Side Effects Induced by Cotrimoxazole at the ALNADJMA Multipurpose Center in N'Djamena, Chad

  2025cites this paper
• Symbiotic gut bacteria found capable of producing detoxification enzymes aiding their host, a polyphagous herbivore, Spodoptera litura (Fab.) in its xenobiotic adaptation

  2025cites this paper
• Unraveling the Role of CYP2E1 in Antitubercular Drug–Induced Hepatotoxicity: From Molecular Mechanisms to Clinical Implications

  2025cites this paper
• Nasal xenobiotic metabolizing enzymes: at the crossroads of toxicity, detoxification, and olfaction.

  2025cites this paper
• The Nature of Nanodisc Lipids Influences Fragment‐Based Drug Discovery Results

  2025cites this paper
• Computational Studies of Enzymes for C-F Bond Degradation and Functionalization.

  2025cites this paper
• From closed to open: three dynamic states of membrane-bound cytochrome P450 3A4

  2025cites this paper
• Electricity-driven site-selective deuteration of pharmaceuticals

  2025cites this paper
• Discovery of Metabolic Cross-Coupling in Phenol-Arylamine Mixtures by Cytochrome P450 via Combined Computational and Experimental Approaches.

  2025cites this paper
• Research on the content and activity of CYP450 enzymes in human liver

  2025cites this paper
• DiffMeta-RL: Reinforcement Learning-Guided Graph Diffusion for Metabolically Stable Molecular Generation

  2025cites this paper
• Interactive Effects of Copper Contamination and Salinization Across Multiple Genotypes of Daphnia magna

  2025cites this paper
• Design, synthesis, deep learning-guided prediction, and biological evaluation of novel pyridine-thiophene-based imine-benzalacetophenone hybrids as promising antimicrobial agent

  2025cites this paper
• Targeted renal cyto-protection by medicarpin against acyclovir-induced nephrotoxicity via regulating SIRT1/FOXO3a and endothelin axis: An experimental and computational analysis.

  2025cites this paper
• Stereo- and Regioselective Metabolism of the Omeprazole Enantiomers by CYP2C19: Insights from Binding Free Energy and QM/MM Calculations in a Curtin–Hammett Framework

  2025cites this paper
• Synergistic Exploration of Thiazole Derivatives: Synthesis, Antimicrobial Activity and Computational Insights

  2025cites this paper
• Bio-Simulation Studies of Valganciclovir Hydrochloride: Molecular Descriptor-Based QSAR Modelling and Swiss ADME Analysis Using in silico Models

  2025cites this paper
• In silico exploration of bioactive secondary metabolites with anesthetic effects on sodium channels Nav 1.7, 1.8, and 1.9 in painful human dental pulp

  2025cites this paper
• Safety and Effectiveness of Pravastatin in Korean Patients with Dyslipidemia Based on the Cardiovascular Risk Classification: Pooled Analysis of Four Observational Studies

  2025cites this paper
• The effects of sulfate on the physiology, biochemistry, and intestinal transcriptome of Scylla paramamosain under low-salinity conditions.

  2025cites this paper
• Artificial intelligence to predict inhibitors of drug-metabolizing enzymes and transporters for safer drug design

  2025cites this paper
• ArcDFI: Attention regularization guided by CYP450 interactions for predicting drug-food interactions

  2025cites this paper
• Leveraging Machine Learning for Predicting Molecular Refractivity in Drug Toxicology

  2025cites this paper
• Metabolic Characteristics of Schisantherin B in Mice with Metabolic-Associated Fatty Liver Disease

  2025cites this paper
• A Perspective on Unintentional Fragments and Their Impact on the Dark Metabolome, Untargeted Profiling, Molecular Networking, Public Data, and Repository Scale Analysis

  2025cites this paper
• Guanine nucleoside alleviates mycophenolic acid-induced toxicity in mouse embryonic stem cells

  2025cites this paper
• Data-driven cluster analysis identifies distinct types of cardiovascular-kidney-metabolic syndrome.

  2025cites this paper
• Differential Proteomic Analysis of DEN-Induced Hepatocellular Carcinoma in Male and Female Balb/c Mice Reveals Novel Gender Specific Markers

  2025cites this paper
• Beyond Mimicking Enzymes: NewTAML/Peroxide Abstracts sp3 C–H Bonds to Initiate Biotranscendent Water-Purifying Mineralization of Fluoroquinolone Antibiotics

  2025cites this paper
• Integrated ADME, metabolomics, and multi-target docking of Novel methoxy- and thiophene-substituted benzodioxane hydrazones.

  2025cites this paper
• Фармакофорне моделювання селективної взаємодії лігандів з ізоформами цитохрому P450

  2025cites this paper
• The Effects of Obesity on Lung Physiology, the Prevalence and Severity of Chronic Pulmonary Diseases, and Inhalation Treatment

  2025cites this paper
• Dietary Modulation of CYP3A4 and Its Impact on Statins and Antidiabetic Drugs: A Narrative Review

  2025cites this paper
• Crystal Structure Investigation, DFT Calculations, Molecular Dynamic Study of a New Imidazole as a Potent Inhibitor of Microbial Hormone‐Sensitive Lipase‐ E53

  2025cites this paper
• "Lemongrass vs. rare disease: Unveiling the therapeutic promise of Cymbopogon citratus essential oil against Simpson Golabi Behmel syndrome type 1 (SGBS1) through characterization of phytocompounds, ADME estimation and molecular docking study"

  2025cites this paper
• Comprehensive identification and characterization of in vitro and in vivo metabolites of the novel GLP-1 receptor agonist danuglipron using UHPLC-QToF-MS/MS.

  2025cites this paper
• Urinary Metabolome Study for Monitoring Prostate Cancer Recurrence Following Radical Prostatectomy

  2025cites this paper
• Synthesis, Characterization, and Computational Insights of Flavone Derivatives as Promising Antimicrobial Agents

  2025cites this paper
• CoTox: Chain-of-Thought-Based Molecular Toxicity Reasoning and Prediction

  2025cites this paper
• Diisopromine as a non-labelled CYP3A4 substrate: Implications for breath test development.

  2025cites this paper
• Exploring Oxazolidinone scaffolds for future antibiotics: synthesis and computational insights with DFT, docking, ADME and MD simulation

  2025cites this paper
• Recent Advancements in the Prevention and Treatment of Genetic and Non-Genetic Obesity: A Pharmacological Perspective of Review

  2025cites this paper
• Catalytic reduction of NAD(P)+ to NAD(P)H.

  2025cites this paper
• New players from the old chalcone scaffold: Synthesis, identification, and characterization of new potent ABCG2 inhibitors.

  2025cites this paper
• Design, Synthesis, and Molecular Docking Studies of Novel Pyrazoline-Thiazoles as Cholinesterase Dual-Target Inhibitors for the Treatment of Alzheimer’s Disease

  2025cites this paper
• Preclinical Evaluation of 2-Aminobenzothiazole Derivatives: In Silico, In Vitro, and Preliminary In Vivo Studies as Diabetic Treatments and Their Complications

  2025cites this paper
• Insect Cytochrome P450 Database: An Integrated Resource of Genetic Diversity, Evolution and Function

  2025cites this paper
• Biocompatible synthesis, computational studies and therapeutic evaluation of a dibutyl (2,2‐dicyano‐1‐phenylethyl) phosphonate derivatives targeting oxidative stress, microbial infection and cancer cells

  2025cites this paper
• Efficient Whole-Cell Biocatalytic Production of 7α-Hydroxy-4-cholesten-3-one via Human CYP7A1 Expressed in Escherichia coli.

  2025cites this paper
• Recent Advances in Elucidating the Mechanism of the NADPH–Cytochrome P450 Reductase-Mediated Electron Transfer Cycle: Experimental and Computational Perspectives

  2025cites this paper
• High Throughput Virtual Screening of Phosphodiesterase type-5 (PDE-5) inhibitors against Erectile Dysfunction from Saussurea lappa roots: An Integrated Approach Utilizing GC-MS, Machine Learning, Docking, Molecular Dynamics, and DFT based analysis

  2025cites this paper
• Cytochrome P450 Enzyme-Mediated Enantioselective Biotransformation of Chiral Fungicide Tebuconazole in Earthworm.

  2025cites this paper
• Effects of the Novel Triazole Fungicide Ipfentrifluconazole on Different Endpoints in Zebrafish Larvae

  2025cites this paper
• Interactions of Linalool and Linalyl Acetate with Selected Dog Cytochrome P450 (CYP) Proteins Identified by In Silico Drug Discovery Followed by Molecular Docking Analysis

  2025cites this paper
• Integrating immunity, antioxidative status, and gene regulation against nickel and high-temperature stress in fish: selenium nanoparticles for mitigation

  2025cites this paper
• Canine duodenal organoids as a functional platform for intestinal CYP regulation and drug metabolism studies

  2025cites this paper
• Environmental Microbial Cues Alter Embryonic Development and Stress Responses in Vertebrates: Insights From the Zebrafish (Danio rerio) Model

  2025influential citation
• Synthesis and exploration of breast cancer agent from curcumin analogs based on 3-benzyloxybenzaldehyde

  2025cites this paper
• Heme-thiolate monooxygenase cytochrome P450 1B1, an old dog with many new tricks.

  2025cites this paper
• Quantum Chemical Evaluation and QSAR Modeling of N-Nitrosamine Carcinogenicity.

  2025cites this paper
• Characterization of CYP3A genes and the impact of letrozole on gonadal development in Apostichopus japonicus

  2025cites this paper
• Identification of In Vivo and In Vitro Metabolites of Fentanyl Using UHPLC-Q-Orbitrap-HRMS.

  2025cites this paper
• Extrapolation of PBBs Environmental Transformation Mechanisms and Toxicity Risks of Byproducts

  2025cites this paper
• A machine learning approach to predict treatment efficacy and adverse effects in major depression using CYP2C19 and clinical-environmental predictors

  2025cites this paper
• GLMCyp: A Deep Learning-Based Method for CYP450-Mediated Reaction Site Prediction

  2025cites this paper
• Relationships between liver and rumen fluke infections, milk somatic cells and polymorphisms in the Toll-like receptor 5 gene and vitamin D metabolism-related genes in Holstein dairy cows.

  2025cites this paper
• A simplified LC–MS-based method for sensitive analysis of DNA adducts utilizing accessible in vitro metabolism models

  2025cites this paper
• In Silico Pharmacological and Pharmacokinetic Study of Marmeline From Bael Fruit for the Treatment of Alzheimer’s Disease

  2025cites this paper
• The Hunt for the Putative Epoxyeicosatrienoic Acid Receptor

  2025cites this paper
• Synthesis of Benzo[h]quinoline derivatives and evaluation of their insecticidal activity against Culex pipiens L. larvae.

  2025cites this paper
• Turning Over an Old Leaf- do Mammalian Herbivores Retain the Ability to Biotransform Toxic Ancestral Diets?

  2025cites this paper
• Molecular Mechanisms and Biomarker-Based Early-Warning Indicators of Heavy Metal Toxicity in Marine Fish

  2025cites this paper